Karl Kelley
Direttore Tecnico/Scientifico/R&S presso RAIsonance, Inc.
Profilo
Karl D.
Kelley currently works as a Director & Chief Medical Officer at RAIsonance, Inc.
Posizioni attive di Karl Kelley
| Società | Posizione | Inizio |
|---|---|---|
RAIsonance, Inc.
 RAIsonance, Inc. Information Technology ServicesTechnology Services RAIsonance, Inc. is a family of companies based in the Denver Tech Center that specializes in artificial intelligence/machine learning-based healthcare solutions. The American company operates wellness products such as MyAdvocate and Biometric SoundPass for consumers, and the workforce wellness solution FCV Sentinel for the enterprise. Additionally, RAIsonance is developing diagnostic solutions for COVID-19, influenza, tuberculosis, and RSV. Originally funded with a grant from the National Science Foundation, RAIsonance has developed breakthrough technology innovations that use signal data signature recognition as a biomarker for human medical diagnostics and to support ground-breaking safety applications. The company was founded in 2020 by Catherine M. Kolding, who has been the CEO since then. | Direttore Tecnico/Scientifico/R&S | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 1 |
|---|---|
RAIsonance, Inc.
RAIsonance, Inc. Information Technology ServicesTechnology Services RAIsonance, Inc. is a family of companies based in the Denver Tech Center that specializes in artificial intelligence/machine learning-based healthcare solutions. The American company operates wellness products such as MyAdvocate and Biometric SoundPass for consumers, and the workforce wellness solution FCV Sentinel for the enterprise. Additionally, RAIsonance is developing diagnostic solutions for COVID-19, influenza, tuberculosis, and RSV. Originally funded with a grant from the National Science Foundation, RAIsonance has developed breakthrough technology innovations that use signal data signature recognition as a biomarker for human medical diagnostics and to support ground-breaking safety applications. The company was founded in 2020 by Catherine M. Kolding, who has been the CEO since then. | Technology Services |
- Borsa valori
- Insiders
- Karl Kelley
